REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Edupharma (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: UAB Edupharma Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Edupharma is an enterprise located in Lithuania, with the main office in Kaunas. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on September 29, 2010. 8 (2025) employees currently work for UAB Edupharma. There was a net sales revenue drop of 28.61% reported in UAB Edupharma’s latest financial highlights for 2024. The net profit margin of UAB Edupharma decreased by 11.01% in 2024.

Headquarters
K. Barsausko g. 80
Kaunas; Kaunas County; Postal Code: LT-51440

Contact Details: Purchase the UAB Edupharma report to view the information.

Basic Information
Total Employees:
Purchase the UAB Edupharma report to view the information.
Registered Capital:
Purchase the UAB Edupharma report to view the information.
Financial Auditors:
Purchase the UAB Edupharma report to view the information.
Incorporation Date:
September 29, 2010
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after UAB Edupharma report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-28.61%
Total operating revenue
-28.61%
Net Profit (Loss) for the Period
-99.02%
Total Equity
-37.73%
Net Profit Margin
-11.01%
Return on Equity (ROE)
-37.71%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?